A Detailed Look at 2018 Securities Litigation Against Life Sciences Companies

As I have previously noted, 2018 was another extraordinary year for U.S. securities class action litigation, as filings overall remained at near-historical rates. One of the significant contribution factors to this development was the substantial number of securities suits filed against life sciences companies. The number and significance of the securities suits filed against life sciences companies is detailed in a February  6, 2019 report from the Dechert law firm entitled “Dechert Survey: Developments in U.S. Securities Fraud Class Actions Against Life Sciences Companies: 2018 Edition” (here).   According to the Dechert report, there were a total of 86 securities class action lawsuits filed against life sciences companies in 2018, slightly below the 88 filed in 2017, but more 350% greater than the 19 filed just five years ago in 2013. The number of suits against life sciences companies during 2018 was so great that life science-related lawsuits…

Read more detail on Recent Corporate Law Department posts –

Related news:

This entry was posted in Corporate Law and tagged , , , , , , , , . Bookmark the permalink.

Leave a Reply